Cargando…

Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease

SIMPLE SUMMARY: Cellular identity and function depends on the correct and specific expression of genetic information. Different epigenetic mechanisms including DNA methylation, modifications of histones, and expression of non-coding RNAs control chromatin structure and DNA accessibility to the trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arechederra, María, Recalde, Miriam, Gárate-Rascón, María, Fernández-Barrena, Maite G., Ávila, Matías A., Berasain, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998165/ https://www.ncbi.nlm.nih.gov/pubmed/33809263 http://dx.doi.org/10.3390/cancers13061265

Ejemplares similares

SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
por: Gárate-Rascón, María, et al.
Publicado: (2022)

Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
por: Fernández-Barrena, Maite G., et al.
Publicado: (2020)

The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
por: Recalde, Miriam, et al.
Publicado: (2021)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
por: Recalde, Miriam, et al.
Publicado: (2022)

Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
por: Canale, Matteo, et al.
Publicado: (2020)

Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
por: Arechederra, María, et al.
Publicado: (2020)

La biopsia líquida en el manejo del cáncer: una nueva herramienta revolucionaria de la medicina de precisión, aún con limitaciones
por: Arechederra, María, et al.
Publicado: (2020)

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
por: Herranz, Jose M., et al.
Publicado: (2023)

Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
por: Berasain, Carmen, et al.
Publicado: (2020)

New mechanisms involving the EGFR and FGF15/19 systems in liver regeneration and carcinogenesis
por: Berasain, Carmen, et al.
Publicado: (2014)

Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins
por: Jiménez, Maddalen, et al.
Publicado: (2019)

Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis
por: Barcena-Varela, Marina, et al.
Publicado: (2019)

Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2−/− Mice
por: Latasa, M. Ujue, et al.
Publicado: (2010)

Epigenetic remodelling in human hepatocellular carcinoma
por: Braghini, Maria Rita, et al.
Publicado: (2022)

Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice
por: Alvarez-Sola, Gloria, et al.
Publicado: (2017)

Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular Carcinoma
por: Avila, Matías A., et al.
Publicado: (2018)

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
por: Chen, Chaobo, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer
por: Berasain, Carmen, et al.
Publicado: (2011)

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning
por: Iñiguez, Maria, et al.
Publicado: (2006)

Impact of Alternative Splicing Variants on Liver Cancer Biology
por: Marin, Jose J. G., et al.
Publicado: (2021)

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
por: Colyn, Leticia, et al.
Publicado: (2022)

MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
por: Fernández-Ramos, David, et al.
Publicado: (2018)

HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
por: Loi, Eleonora, et al.
Publicado: (2022)

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
por: Arechederra, Maria, et al.
Publicado: (2022)

Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease
por: Simile, Maria M., et al.
Publicado: (2016)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
por: Gonzalez-Sanchez, Ester, et al.
Publicado: (2021)

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
por: Villa, Chiara, et al.
Publicado: (2022)

Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review
por: Altuna, Miren, et al.
Publicado: (2022)

Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
por: Schott, Mandy, et al.
Publicado: (2022)

Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
por: Meroni, Marica, et al.
Publicado: (2018)

Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach
por: Urman, Jesús M., et al.
Publicado: (2020)

PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease
por: Blanco-Luquin, Idoia, et al.
Publicado: (2018)

Epigenetics in liver disease
por: Mann, Derek A
Publicado: (2014)

FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations
por: Morón-Ros, Samantha, et al.
Publicado: (2020)

Epigenetic Biomarkers in Cardiovascular Diseases
por: Soler-Botija, Carolina, et al.
Publicado: (2019)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

The Role of Epigenetic and Biological Biomarkers in the Diagnosis of Periodontal Disease: A Systematic Review Approach
por: Faulkner, Erin, et al.
Publicado: (2022)

Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System
por: Latasa, Maria U., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_htmn26uunibem6tktdbdb8bo2t